News

Public · Published

HNGE: Revenue grew 52%, margins expanded, and FY guidance rose on stronger yield

HNGE reported third-quarter revenue of $235 million, up 52% from a year earlier. Operating margin was 33% and adjusted free cash flow was $120 million. The company raised its full-year 2026 guidance, citing stronger yield and eligible lives.

Published:

Updated:

What happened

HNGE reported third-quarter revenue of $235 million, up 52% from a year earlier. Operating margin was 33% and adjusted free cash flow was $120 million. The company raised its full-year 2026 guidance, citing stronger yield and eligible lives.

Confirmed

Global impact / market context

Faster revenue with a 33% operating margin means HNGE keeps more profit per sale while growing. The $120 million in adjusted free cash flow is cash available for reinvestment or other uses. A raised 2026 outlook signals management expects stronger yield and more eligible lives to sustain growth.

Analyst inference

HNGE's core musculoskeletal business, called MSK, remains central, while Migraine and GI expand the platform. The 52% growth rate and higher guidance may shape how investors view the company's growth prospects and profitability compared with prior expectations.

Analyst inference

What to watch

  1. Watch whether full-year 2026 guidance is met, since the raised outlook rests on stronger yield and eligible lives, which are the drivers the article names. Confirmed
  2. Track whether MSK stays core while Migraine and GI expand the platform, and whether that broader mix supports revenue growth and operating margin over coming quarters. Proposed
  3. Watch adjusted free cash flow, which is cash available after running costs, because $120 million shows how much cash the business generates to fund growth. Analyst inference

Evidence

  • Original source link unavailable